About VaccineNation
The Vaccine Nation blog will cover all the latest developments in the vaccine space from basic immunology to manufacture and access, across all diseases. Visit us regularly to get updates on COVID, find the most innovative platforms and see how the industry is constantly adapting its public and private health investments.
Our key themes will be split under:
Therapeutic
Technology
Infection
Global Health
We are the team behind the biggest and most established vaccine meetings: World Vaccine Congress Series that take place 3 times a year in Washington D.C., San Diego and Europe.
World Vaccine Congress Europe
World Vaccine & Immunotherapy Congress
World Vaccine Congress Washington
MOST POPULAR THIS MONTH
UNITAID’s “Landscape” of tools and strategies
UNITAID published a report in August 2022 to examine the “landscape of tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis B, and Chagas. Mother-to-child transmission is also known as vertical transmission. The report...
UK’s first human Brucella canis case confirmed
The European Scientific Counsel Companion Animal Parasites (ESCCAP) called for compulsory testing of imported dogs after the UK’s first case of dog-to-human transmission of Brucella canis (B canis). This causes an infectious disease called canine brucellosis, with a...
WHO updates guidance for Tuberculosis response
In August 2022 the WHO announced new guidance to “support national strategic planning” for tuberculosis (TB) responses. This guidance was described as a culmination of the “latest WHO guidelines” by Dr Tereza Kasaeva, Director of WHO’s Global Tuberculosis Programme. ...
UK’s JCVI updates Covid-19 booster programme
In August 2022 the UK's Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will be used for each group in autumn. The JCVI emphasised that every option on the list provides protection against “severe illness” from Covid-19....
White paper from IDT Biologika: oncolytic viruses
In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing oncolytic viruses and how to avoid problems. Oncolytic viruses (OVs) have the “potential to revolutionise standard cancer treatment”. Researchers continue to...
mRNA vaccine for cancer shows promise at Tufts University
A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes instead of the liver. Researchers at Tufts School of Engineering believe that this method is “so strong and precise, it eliminates tumours and even prevents their...
Avian influenza restrictions lifted in the UK
In August 2022 the UK’s Chief Veterinary Office, Professor Christine Middlemiss, appealed to bird keepers to maintain enhanced biosecurity measures after an avian influenza outbreak. Restrictions lifted on 16th August, but Professor Middlemiss is keen to ensure that...
UK approves Moderna’s dual vaccine against Covid
The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced in August 2022 that it approved Moderna’s bivalent vaccine, Spikevax Bivalent Original/Omicron, against two forms of Covid. Dr June Raine, chief executive of the MHRA, stated that the “first...
